• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Highly sensitive method to detect potential cancer biomarker

Bioengineer by Bioengineer
January 31, 2019
in Cancer
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New platform created using molecular imprinting technology

IMAGE

Credit: Kobe University


Exosomes regulate intercellular communication in cancers, and are drawing attention as a potential cancer biomarker. A Japanese research group has developed a highly sensitive method for detecting these exosomes that could potentially contribute to early detection of cancer.

The research group was focused around faculty in the Kobe University Medical Device Fabrication Engineering Center, led by Professor Toshifumi Takeuchi (Kobe University Graduate School of Engineering) and Professor Ryohei Sasaki (Kobe University Hospital), in collaboration with Kazuyuki Hamada (System Instruments Co., Ltd.). The findings were published on January 3 in Angewandte Chemie International Edition, and featured on the inner cover of the journal.

Exosomes are membrane vesicles consisting of lipid bilayer that measure only about 100 nanometers and are discharged from various cells. Exosomes secreted from cancer cells are closely linked to cancer migration, invasion, and metastasis. By examining these cancer-secreted exosomes, we may be able to develop a new method for early detection of cancer.

Current exosome analysis methods involve complicated and time-consuming procedures, including a combination of ultracentrifugation and affinity separation. If we could differentiate cancer-secreted exosomes from other exosomes in body fluids without complicated pretreatments, this would enable a simple test for early detection of cancer.

Using molecular imprinting technology (Figure 1) [1], the team prepared an artificial polymer film of about 30 nanometers, possessing cavities the size of an exosome on top of the glass substrate (an exosome-binding cavity). Then, using their own post-imprinting technology [2], the researchers selectively introduced antibodies that can recognize membrane proteins on the surface of exosomes, and fluorescent molecules that can report exosome binding information. This resulted in an exosome-sensing chip (Figure 2), a groundbreaking, highly-sensitive fluorescence detection chip combining antibodies and artificial materials. It recognizes the membrane proteins on exosomes, captures the exosomes, and reports the information via changes in fluorescence.

To simplify exosome analysis using this fluorescence-based sensing platform, the team collaborated with System Instruments Co., Ltd. to create a device that automatizes the whole analysis process (Figure 3). This instrument is a highly sensitive CMOS camera-mounted fluorescence microscope equipped with a 3D robot arm. With a custom-made flat-type pipette tip inserted with the exosome sensing substrate, it can automatically carry out suction, discharge, fluorescence detection and substrate cleaning of the samples. Using this equipment, with no pretreatment and within 10 minutes, the team achieved unprecedented high-sensitivity detection of 6 picograms per milliliter. This technology enables us to detect about 150 exosomes in 10 microliters, a level of sensitivity that far surpasses previously reported measuring techniques.

The device was created with the support of the Foundation for Biomedical Research and Innovation at Kobe (President: Nobel Prize Laureate Tasuku Honjo).

For early detection of cancer, we need pre-checks before the disease takes hold, but currently the complexity of these checks means that only a small proportion of people are screened. The instrument developed in this study makes it easier to analyze the exosomes in bodily fluids. “Going forward, we will collect clinical samples on a large scale and carry out exosome analysis,” comments Professor Takeuchi. “If it can be verified that analyzing cancer-secreted exosomes are helpful in cancer screenings, this will contribute to increasing the number of screenings. It can also be applied to cancer tests, treatment effectiveness, predictions of cancer transferal, and post-treatment prognoses.”

###

[1] T. Takeuchi, T. Hayashi, S. Ichikawa, A. Kaji, M. Masui, H. Matsumoto, R. Sasao, Chromatography 2016, 37, 43-64 (Focusing Review, Open access).

[2] T. Takeuchi, H. Sunayama, Chem. Commun. 2018, 54, 6243-6251 (Feature Article).

Media Contact
Eleanor Wyllie
[email protected]

Original Source

http://www.kobe-u.ac.jp/research_at_kobe_en/NEWS/news/2019_01_31_01.html

Related Journal Article

http://dx.doi.org/10.1002/anie.201811142

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologycancerCell BiologyDiagnosticsHealth Care Systems/ServicesMaterialsMedicine/HealthNanotechnology/MicromachinesPolymer Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

New Open-Source Data Platform Launched to Advance Lung Cancer Genetics Research

September 8, 2025

Overcoming Resistance Mutations and the Blood–Brain Barrier: Major Challenges in Targeted Therapy for Brain Metastases in Non-Small Cell Lung Cancer

September 8, 2025

Moffitt Creates First Genetically Engineered Cancer Model in Naked Mole Rats

September 8, 2025

IU Scientists Reengineer Cancer-Protective Regulatory T Cells to Combat Tumors

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Open-Source Data Platform Launched to Advance Lung Cancer Genetics Research

AI Reveals Stress Levels in Farmed Amazonian Fish, New Study Shows

Overcoming Resistance Mutations and the Blood–Brain Barrier: Major Challenges in Targeted Therapy for Brain Metastases in Non-Small Cell Lung Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.